Abstract
Paroxysmal nocturnal hemoglobinuria (PNH) is an acquired stem cell disorder characterized by intravascular hemolysis and thrombosis. The most serious complication is thrombosis, the risk of which is augmented by the hyper-coagulable state that occurs during pregnancy; despite this risk, however, young female PNH patients often desire to have a baby. We recently experienced two successful deliveries in PNH patients, who were treated with anticoagulant therapy during their pregnancies. Meanwhile, given the potential benefit of eculizumab (Soliris), a humanized monoclonal antibody against C5, in reducing thrombosis and hemolysis, it represents a promising therapeutic option for the treatment of pregnant PNH patients in combination with, or in replacement of, anticoagulant therapy.
References
Parker C, Omine M, Richards S, Nishimura J, Bessler M, Ware R, et al. Diagnosis and management of paroxysmal nocturnal hemoglobinuria. Blood. 2005;106:3699–709.
Takeda J, Miyata T, Kawagoe K, Iida Y, Endo Y, Fujita T, et al. Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria. Cell. 1993;73:703–11.
Hillmen P, Lewis SM, Bessler M, Luzzatto L, Dacie JV. Natural history of paroxysmal hemoglobinuria. N Engl J Med. 1995;333:1253–8.
Shichishima T, Saitoh Y, Noji H, Terasawa T, Maruyama Y. In vivo effects of various therapies on complement-sensitive erythrocytes in paroxysmal nocturnal hemoglobinuria. Int J Hematol. 1996;6:291–302.
Issaragrisil S, Piankijagum A, Tang-naitrisorana Y. Corticosteroids therapy in paroxysmal nocturnal hemoglobinuria. Am J Hematol. 1987;25:77–83.
Hillmen P, Hall C, Marsh JC, Elebute M, Bombara MP, Petro BE, et al. Effect of eculizumab on hemolysis and transfusion requirements in patients with paroxysmal nocturnal hemoglobinuria. N Engl J Med. 2004;350:552–9.
Hillmen P, Young NS, Schubert J, Brodsky RA, Socié G, Muus P, et al. The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria. N Engl J Med. 2006;355:1233–43.
Brodsky RA, Young NS, Antonioli E, Risitano AM, Schrezenmeier H, Schubert J, et al. Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria. Blood. 2008;111:1840–7.
Kanakura Y, Ohyashiki K, Schishima T, Okamoto S, Ando K, Ninomiya H, et al. Safety and efficacy of the terminal complement inhibitor eculizumab in Japanese patients with paroxysmal nocturnal hemoglobinuria: the AEGIS clinical trial. Int J Hematol. 2011;93:36–46.
Socie G, Mary JY, de Gramont A, Rio B, Leporrier M, Rose C, et al. Paroxysmal nocturnal haemoglobinuria: long-term follow-up and prognostic factors. Lancet. 1996;31:573–7.
Hillmen P, Muus P, Dührsen U, Risitano AM, Schubert J, Luzzatto L, et al. Effect of the complement inhibitor eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuria. Blood. 2007;110:4123–8.
Nishimura J, Kanakura Y, Ware RE, Shichishima T, Nakakuma H, Ninomiya H, et al. Clinical course and flow cytometric analysis of paroxysmal nocturnal hemoglobinuria in the United States and Japan. Medicine. 2004;83:193–207.
Bais J, Pel M, von dem Borne A, van der Lelie H. Pregnancy and paroxysmal nocturnal hemoglobinuria. Eur J Obstet Gynecol Reprod Biol. 1994;53:211–4.
Tichelli A, Socie G, Marsh J, Barge R, Frickhofen N, McCann S, et al. Outcome of pregnancy and disease course among women with aplastic anemia treated with immunosuppression. Ann Intern Med. 2002;136:164–72.
James AH, Tapson VF, Goldhaber SZ. Thrombosis during pregnancy and the postpartum period. Am J Obstet Gynecol. 2005;193:216–9.
Ray JG, Burows RF, Ginsberg JS, Burrows EA. Paroxysmal nocturnal hemoglobinuria and the risk of venous thrombosis: review and recommendations for management of the pregnant and nonpregnant patient. Haemostasis. 2000;30:103–17.
Hall C, Richards S, Hillmen P. Primary prophylaxis with warfarin prevents thrombosis in paroxysmal nocturnal hemoglobinuria (PNH). Blood. 2003;102:3587–91.
Ray JG, Chan WS. Deep vein thrombosis during pregnancy and the puerperium: a meta-analysis of the period of risk and the leg of presentation. Obstet Gynecol Surv. 1999;54:265–71.
Moyo VM, Mukhina GL, Garrett ES, Brodsky RA. Natural history of paroxysmal nocturnal haemoglobinuria using modern diagnostic assays. Br J Haematol. 2004;126:133–8.
Danilov AV, Brodsky RA, Craigo S, Smith H, Miller KB. Managing a pregnant patient with paroxysmal nocturnal hemoglobinuria in the era of eculizumab. Leuk Res. 2010;34:566–71.
Greer IA, Nelson-Piercy C. Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy. Blood. 2005;106:401–7.
Meyers G, Parker CJ. Management issues in paroxysmal nocturnal hemoglobinuria. Int J Hematol. 2003;77:125–32.
Bjørge L, Ernst P, Haram KO. Paroxysmal nocturnal hemoglobinuria in pregnancy. Acta Obstet Gynecol Scand. 2003;82:1067–71.
Allen TK, George RB, Olufolabi AJ, James AH, Muir HA, Habib AS. The management of Cesarean delivery in a parturient with paroxysmal nocturnal hemoglobinuria complicated by severe preeclampsia. Can J Anaesth. 2007;54:646–51.
Solal-Céligny P, Tertian G, Fernandez H, Pons JC, Lambert T, Najean Y, et al. Pregnancy and paroxysmal nocturnal hemoglobinuria. Arch Intern Med. 1988;148:593–5.
de Guibert S, Peffault de Latour R, Varoqueaux N, Labussière H, Rio B, Jaulmes D, et al. Paroxysmal nocturnal hemoglobinuria and pregnancy before the eculizumab era: the French experience. Haematologica. 2011;96:1276–83.
Melo A, Gorgal-Carvalho R, Amaral J, Marques MC, Andrade J, Guimarães JT, et al. Clinical management of paroxysmal nocturnal haemoglobinuria in pregnancy: three case reports. Blood Transfus. 2011;9:99–103.
Greene MF, Frigoletto FD Jr, Claster S, Rosenthal D. Pregnancy and paroxysmal nocturnal hemoglobinuria: report of a case and review of the literature. Obstet Gynecol Surv. 1983;38:591–6.
Shibasaki T, Matsuda H, Furuya K. Haptoglobin therapy during pregnancy for paroxysmal nocturnal hemoglobinuria with renal failure. Int J Gynaecol Obstet. 2007;98:267–8.
Chen ML, Yu CH, Chang FM, Kuo PL. Paroxysmal nocturnal hemoglobinuria superimposed with preeclampsia. Taiwan J Obstet Gynecol. 2006;45:276–8.
Fieni S, Bonfanti L, Gramellini D, Benassi L, Delsignore R. Clinical management of paroxysmal nocturnal hemoglobinuria in pregnancy: a case report and updated review. Obstet Gynecol Surv. 2006;61:593–601.
Paech MJ, Pavy TJ. Management of a parturient with paroxysmal nocturnal haemoglobinuria. Int J Obstet Anesth. 2004;13:188–91.
Kjaer K, Comerford M, Gadalla F. General anesthesia for cesarean delivery in a patient with paroxysmal nocturnal hemoglobinuria and thrombocytopenia. Anesth Analg. 2004;98:1471–2.
Higgins SP, McMahon LP, Brennecke SP. Paroxysmal nocturnal haemoglobinuria in pregnancy—not to be confused with pre-eclampsia or HELLP syndrome. Case report and literature review. J Obstet Gynaecol. 2004;24:83–5.
Stocche RM, Garcia LV, Klamt JG. Labor analgesia in a patient with paroxysmal nocturnal hemoglobinuria with thrombocytopenia. Reg Anesth Pain Med. 2001;26:79–82.
Svigos JM, Norman J. Paroxysmal nocturnal haemoglobinuria and pregnancy. Aust N Z J Obstet Gynaecol. 1994;34:104–6.
Imai A, Takagi H, Kawabata I, Sumi H, Shiraki S, Tamaya T. Successful pregnancy in a patient with paroxysmal nocturnal hemoglobinuria: case report. Arch Gynecol Obstet. 1989;246:121–4.
Mori H, Okada S, Takizawa Y, Hagiwara S, Niikura H, Terada H. Pregnancy in paroxysmal nocturnal hemoglobinuria–report of two cases. Rinsho Ketsueki. 1987;28:1645–50.
Beresford CH, Gudex DJ, Symmans WA. Paroxysmal nocturnal haemoglobinuria and pregnancy. Lancet. 1986;2:1396–7.
Jacobs P, Wood L. Paroxysmal nocturnal haemoglobinuria and pregnancy. Lancet. 1986;2:1099.
Tomaru T, Nakai K, Takeda S, Kagawa T, Ozawa K. Anesthetic management of caesarean section in a patient with paroxysmal nocturnal hemoglobinuria. Masui. 1986;35:807–11.
Colvin BT. Thrombocytopenia. Clin Haematol. 1985;14:661–81.
Hurd WW, Miodovnik M, Stys SJ. Pregnancy associated with paroxysmal nocturnal hemoglobinuria. Obstet Gynecol. 1982;60:742–6.
Wozniak AJ, Kitchens CS. Prospective hemostatic studies in a patient having paroxysmal nocturnal hemoglobinuria, pregnancy, and cerebral venous thrombosis. Am J Obstet Gynecol. 1982;142:591–3.
Kawamura S, Shiosaka T, Saito S, Ikeda K, Matsumoto I, Fujita S, et al. A case of paroxysmal nocturnal hemoglobinuria; successful gestation and labor. Rinsho Ketsueki. 1980;21:1226–31.
Spencer JA. Paroxysmal nocturnal haemoglobinuria in pregnancy: case report. Br J Obstet Gynaecol. 1980;87:246–8.
Frakes JT, Burmeister RE, Giliberti JJ. Pregnancy in a patient with paroxysmal nocturnal hemoglobinuria. Obstet Gynecol. 1976;47:22S–4S.
Payne PR. Paroxysmal nocturnal haemoglobinuria in pregnancy. Proc R Soc Med. 1968;61:679.
Röth A, Hock C, Konik A, Christoph S, Dührsen U. Chronic treatment of paroxysmal nocturnal hemoglobinuria patients with eculizumab: safety, efficacy, and unexpected laboratory phenomena. Int J Hematol. 2011;93:704–14.
Kelly RJ, Hill A, Arnold LM, Brooksbank GL, Richards SJ, Cullen M, et al. The management of pregnancy in paroxysmal nocturnal haemoglobinuria on long term eculizumab. Br J Haematol. 2010;149:446–50.
Figueroa JE, Densen P. Infectious diseases associated with complement deficiencies. Clin Microbiol Rev. 1991;4:359–95.
Rother RP, Rollins SA, Mojcik CF, Brodsky RA, Bell L. Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria. Nat Biotechnol. 2007;25:1256–64.
van Bijnen ST, van Rijn RS, Koljenovic S, Te Boekhorst P, de Witte T, Muus P. Possible high risk of thrombotic events in patients with paroxysmal nocturnal haemoglobinuria after discontinuation of eculizumab. Br J Haematol. 2012;157:762–3.
Marasca R, Coluccio V, Santachiara R, Leonardi G, Torelli G, Notaro R, et al. Pregnancy in PNH: another eculizumab baby. Br J Haematol. 2010;150:707–8.
Acknowledgments
We would like to thank all members of the Working Group on Pregnancy of the Japan PNH Study Group.
Conflict of interest
Drs. Morita Y, Nishimura J, Kanakura Y, and Matsumura I received a Grant for research from Alexion Pharmaceuticals. All other authors declare no conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Morita, Y., Nishimura, Ji., Shimada, T. et al. Successful anticoagulant therapy for two pregnant PNH patients, and prospects for the eculizumab era. Int J Hematol 97, 491–497 (2013). https://doi.org/10.1007/s12185-013-1302-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12185-013-1302-3